Measurement of allelic-expression ratios in trisomy 21 placentas by quencher extension of heterozygous samples identified by partially denaturing HPLC.

BACKGROUND Measuring the allelic ratios of placental transcripts in maternal plasma permits noninvasive prenatal detection of chromosomal aneuploidy. Current methods, however, require highly specialized equipment (MALDI-TOF), limiting the widespread implementation of this powerful RNA single-nucleotide polymorphism (SNP) strategy in routine diagnostic settings. We adapted and applied the Transgenomic WAVE System and quencher extension (QEXT) for this purpose. METHODS The expressed SNP (rs2187247) in exon 2 of the placentally expressed C21orf105 gene (chromosome 21 open reading frame 105) on chromosome 21 was tested in a trisomy 21 model system in which we obtained RNA selectively released from syncytiotrophoblasts of normal and trisomy 21 placentas during first trimester. RESULTS In identifying heterozygous samples, we observed an exact correspondence between sequencing results and results obtained with the WAVE System. With respect to the analysis time required, the WAVE System was superior. In addition, the real-time QEXT assay (as optimized and validated with calibration standards consisting of 262-bp C21orf105 cDNA amplicons) accurately measured allele ratios after we optimized fragment purification, concentrations of input DNA and quencher label, and calculations of reporter signals. Finally, the optimized and validated QEXT assay correctly distinguished normal placentas from trisomy 21 placentas in tests of the following clinically relevant combinations: diploid homozygous (CC), diploid heterozygous (AC), triploid homozygous (AAA), and triploid heterozygous (AAC or ACC). CONCLUSION The QEXT method, which is directly adaptable to current real-time PCR equipment, along with rapid identification of informative samples with the WAVE System, may facilitate routine implementation of the RNA-SNP assay for noninvasive aneuploidy diagnostics.

[1]  M. Blankenstein,et al.  44 single-nucleotide polymorphisms expressed by placental RNA: assessment for use in noninvasive prenatal diagnosis of trisomy 21. , 2007, Clinical chemistry.

[2]  Charles R Cantor,et al.  Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection , 2007, Nature Medicine.

[3]  J. Kingdom,et al.  Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi. , 2006, Placenta.

[4]  S. Drømtorp,et al.  Multiplex real-time single nucleotide polymorphism detection and quantification by quencher extension. , 2006, BioTechniques.

[5]  C. Ding,et al.  MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. C. Chan,et al.  Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling , 2004, Journal of Medical Genetics.

[7]  A. Holck,et al.  Real-time closed tube single nucleotide polymorphism (SNP) quantification in pooled samples by quencher extension (QEXT). , 2003, Nucleic acids research.

[8]  M. Blankenstein,et al.  Detection of chromosome 21-encoded mRNA of placental origin in maternal plasma. , 2003, Clinical chemistry.

[9]  M. van Dijk,et al.  A novel method to identify syncytiotrophoblast-derived RNA products representative of trisomy 21 placental RNA in maternal plasma. , 2008, Methods in molecular biology.

[10]  M. Salto‐Tellez,et al.  Detection of epidermal growth factor receptor variations by partially denaturing HPLC. , 2007, Clinical chemistry.

[11]  K. C. Chan,et al.  Systematic microarray based identification of placental mRNA in maternal plasma : towards non-invasive prenatal gene expression profiling , 2004 .